Daniela Bottero

La Plata, B, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Unadjuvanted antenatal pertussis OMV vaccination drives enhanced and durable humoral immunity in offspring.

Unadjuvanted antenatal pertussis OMV vaccination drives enhanced and durable humoral immunity in offspring.

Journal: Frontiers in immunology
Published: May 16, 2026

Harnessing outer membrane vesicles derived from Bordetella pertussis to overcome key limitations of acellular pertussis vaccines.

Harnessing outer membrane vesicles derived from Bordetella pertussis to overcome key limitations of acellular pertussis vaccines.

Journal: Frontiers in immunology
Published: June 28, 2025

A Survey of Annotated smORF-Encoded Polypeptides in Bacteria Interacting With Eukaryotic Hosts.

A Survey of Annotated smORF-Encoded Polypeptides in Bacteria Interacting With Eukaryotic Hosts.

Journal: Proteomics
Published: December 30, 2024

A Novel Vaccine for Bovine Diarrhea Complex Utilizing Recombinant Enterotoxigenic Escherichia coli and Salmonella Expressing Surface-Displayed Chimeric Antigens from Enterohemorrhagic Escherichia coli O157:H7.

A Novel Vaccine for Bovine Diarrhea Complex Utilizing Recombinant Enterotoxigenic Escherichia coli and Salmonella Expressing Surface-Displayed Chimeric Antigens from Enterohemorrhagic Escherichia coli O157:H7.

Journal: Vaccines
Published: November 25, 2024

Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection.

Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection.

Journal: Frontiers in immunology
Published: October 05, 2024

Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.

Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.

Journal: Frontiers in immunology
Published: August 01, 2023

Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response.

Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response.

Journal: Frontiers in immunology
Published: March 23, 2023

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.

Journal: Frontiers in immunology
Published: August 15, 2022

Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic.

Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic.

Journal: Virology
Published: December 27, 2021

Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.

Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.

Journal: Frontiers in immunology
Published: June 24, 2021

Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions.

Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions.

Journal: Frontiers in medicine
Published: December 11, 2020

Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life.

Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life.

Journal: Frontiers in microbiology
Published: January 31, 2020
Showing 1-12 of 25

Last Updated: 09/26/2026